Traders gather at the booth that trades Abbott Laboratories on the floor of the New York Stock Exchange, in this December 10, 2012 file photo. Abbott Laboratories reported better than expected ... more 
Traders gather at the booth that trades Abbott Laboratories on the floor of the New York Stock Exchange, in this December 10, 2012 file photo. Abbott Laboratories reported better than expected quarterly earnings despite disrupted sales of its infant formulas in China, helped by cost cuts and lower taxes. The company, which spun off its branded prescription drugs business in January into a separate publicly traded company called AbbVie Inc, on October 16, 2013 reported third-quarter earnings from continuing operations of $773 million, or 49 cents per share. REUTERS/Brendan McDermid/Files (UNITED STATES - Tags: BUSINESS) less 
1 / 30
Reuters | Photo By BRENDAN MCDERMID / REUTERS
Wed, Oct 16, 2013 8:18 AM EDT